Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Chigasaki-Shi, Japan Clinical Trials

A listing of Chigasaki-Shi, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

A Phase 1 Study of Tazemetostat in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

This is a multicenter, single-arm, open-label, Phase 1 study to assess the tolerability, safety, pharmacokinetics, and preliminary anti-tumor activity of tazemetostat in participants with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL).

Phase

6.91 miles

Learn More »

A Phase 1 Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies

The primary objective of this study is to evaluate the safety and tolerability of MEDI-551 in Japanese patients with relapsed or refractory advanced B-cell malignancies.

Phase

6.91 miles

Learn More »

Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults

The primary objective of this study is to evaluate the safety and tolerability of Entospletinib (ENTO) monotherapy and in combination with chemotherapy in Japanese participants

Phase

7.13 miles

Learn More »

A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies

This is a multicenter, open-label Phase 1 study of acalabrutinib, a selective and irreversible Bruton's tyrosine kinase inhibitor, in Japanese adult patients with advanced B-cell malignancies. This study is divided into 2 parts: Part 1 (dose-confirmation phase) and Part 2 (dose-expansion phase).

Phase

7.13 miles

Learn More »